Herein, we also found that rapamycin treatment improved novel object recognition memory and rescued LTP deficits in Rab39b KO mice, suggesting that rapamycin may also alleviate symptoms in XLID patients caused by RAB39B mutations. Here, RAB39B is linked to cask-related x-linked intellectual disability.